Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 29,000
-600 (-2.03%)
Oct 31, 2025, 3:30 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 616.3 billion as of October 31, 2025. Its market cap has increased by 0.56% in one year.
Market Cap
616.30B
Enterprise Value
587.13B
Revenue
65.90B
Ranking
n/a
PE Ratio
42.44
Stock Price
29,000.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 616.30B, an increase of 12,822.26%. That is a compound annual growth rate of 22.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 616.30B | -2.50% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | 334.90B | 20.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |